Singapore markets close in 4 hours 13 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
747.47-7.98 (-1.06%)
At close: 04:00PM EST
745.00 -2.47 (-0.33%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close755.45
Bid739.75 x 900
Ask745.49 x 1000
Day's range745.05 - 755.87
52-week range538.01 - 769.63
Avg. volume806,617
Market cap81.401B
Beta (5Y monthly)0.21
PE ratio (TTM)15.14
EPS (TTM)49.36
Earnings date02 Feb 2023 - 06 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est802.25
  • Motley Fool

    Can These 2 Stocks Crush the Market Again in 2023?

    The list includes Regeneron Pharmaceuticals (NASDAQ: REGN) and Biogen (NASDAQ: BIIB). Regeneron was having an unimpressive year on the stock market until its shares soared by double-digit percentages in one day in September. As is often the case with biotechs, Regeneron owes this move to positive clinical developments.

  • Zacks

    Regeneron's (REGN) sBLA for Evkeeza Gets FDA Priority Review

    The FDA accepts for priority review Regeneron's (REGN) sBLA for Evkeeza for treating children aged five to 11 years with homozygous familial hypercholesterolemia. A decision is due on Mar 30, 2023.

  • Motley Fool

    2 Market-Beating Stocks That Can Continue Rising in 2023

    A couple of stocks that have been hot buys this year are Regeneron Pharmaceuticals (NASDAQ: REGN) and T-Mobile US (NASDAQ: TMUS). Unlike the S&P 500, which is down about 17% this year, these two stocks have generated positive returns of 15% or more. Here's a closer look at why both of these stocks can still soar higher in 2023.